Copertina

Real‐World Efficacy and Safety of Dupilumab Retreatment in Adults With Relapsed Atopic Dermatitis: A Retrospective Study From China

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Anda Zhang, Xu Li, Hong Liu, Furen Zhang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Clinical & Experimental Allergy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real‐World Study on Effectiveness and Safety in Dupilumab Nonresponders
di: Mutong Zhao, et al.
Pubblicazione: (2024)

Pathogenesis and Treatment of Atopic Dermatitis: Lessons From China
di: Xu Yao, et al.
Pubblicazione: (2025)

Characteristics and Risk Factors of Dupilumab‐Associated Head and Neck Dermatitis in Patients With Atopic Dermatitis
di: Zifan Li, et al.
Pubblicazione: (2026)

Type 2 Immune‐Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients
di: Coco Dekkers, et al.
Pubblicazione: (2024)

Real‐World Effectiveness and Safety of JAK Inhibitors in Atopic Dermatitis: A Systematic Review and Meta‐Analysis
di: Yunha Kim, et al.
Pubblicazione: (2025)

Dupilumab‐Associated Ocular Surface Disease in Paediatric Atopic Dermatitis Patients: Results From the BioDay Registry
di: Lisa P. van der Rijst, et al.
Pubblicazione: (2025)

Biologic Prescription Patterns and Biomarker Determinants of First‐Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis
di: Marianne Baastrup Soendergaard, et al.
Pubblicazione: (2025)

Step‐Down Dupilumab Dosing Regimen in Patients With Eosinophilic Esophagitis: A Real‐World, Retrospective Study
di: Jerry Fu, et al.
Pubblicazione: (2025)

Associations Between Self‐Reported Dietary Intake and Atopic Dermatitis Risk in Young Adults From Singapore and Malaysia
di: Jun Jie Lim, et al.
Pubblicazione: (2025)

Global Trends in Atopic Dermatitis Burden Among Individuals Under 19 Years From 1990 to 2021
di: Yuke Zhang, et al.
Pubblicazione: (2025)

Dupilumab Efficacy and Safety in Patients With Persistent Asthma: Asia–Pacific Region
di: Qingling Zhang, et al.
Pubblicazione: (2025)

Mixed Sex Disparities in Elderly Atopic Dermatitis Prevalence Among US Oldest‐Old Adults: A Longitudinal Study
di: Minmin Wang, et al.
Pubblicazione: (2025)

Research Integrity in the Field of Atopic Dermatitis Treatment
di: Robert J. Boyle, et al.
Pubblicazione: (2024)

New Topical and Systemic Treatments for Atopic Dermatitis
di: Sara Mirali, et al.
Pubblicazione: (2025)

Effectiveness and Safety of Mepolizumab in Allergic Bronchopulmonary Aspergillosis ( ABPA ): Real‐World Experience From a Chinese Retrospective Case Series
di: Xu Li, et al.
Pubblicazione: (2025)

Asthma and Atopic Dermatitis in Asia, 1990–2021: The Global Burden of Disease Study 2021
Pubblicazione: (2025)

Comment on ‘Effects of Acupuncture as a Therapeutic Intervention Targeting Both Skin and Gastrointestinal Symptoms in Patients With Atopic Dermatitis: A Randomised Controlled Trial’
di: Yintao Zhang, et al.
Pubblicazione: (2026)

Healthy Diet Intervention for Treating Atopic Dermatitis: A Pilot Randomised Controlled Trial
di: Jun Jie Lim, et al.
Pubblicazione: (2026)

Barriers to Seeking Mental Health Services for Atopic Dermatitis Patients and Caregivers
di: Allison R. Loiselle, et al.
Pubblicazione: (2025)

Global Prevalence of Sexual Dysfunction in Individuals With Atopic Dermatitis and Asthma: A Systematic Review and Meta‐Analysis
di: Suh Hyun Kim, et al.
Pubblicazione: (2026)

Early‐Life Secondhand Smoke Exposure and Development of Atopic Dermatitis up to Adulthood
di: Anna Zettergren, et al.
Pubblicazione: (2025)

Changes in Childhood Atopic Dermatitis Incidence and Risk Factors Over Time: Results From Two German Birth Cohorts
di: Zhuoxin Peng, et al.
Pubblicazione: (2025)

Global, Regional and National Burden of Paediatric Atopic Dermatitis: A Trend and Geographic Inequalities Analysis
di: Xueshan Cao, et al.
Pubblicazione: (2024)

Serum Eosinophil‐Derived Neurotoxin (EDN) as a Biomarker for Treatment Response in Atopic Dermatitis
di: J. I. Olydam, et al.
Pubblicazione: (2026)

High Stratum Corneum Hydration May Predict Atopic Dermatitis Development in Moisturised Infants
di: Tomoki Yaguchi, et al.
Pubblicazione: (2025)

DIFENSE Study Protocol: Early Intervention With Difamilast Ointment in Infantile Early‐Onset Atopic Dermatitis for Prevention of Transcutaneous Sensitisation
di: Kiwako Yamamoto‐Hanada, et al.
Pubblicazione: (2025)

Efficacy and Safety of Stapokibart in Adults With Moderate‐to‐Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3 Trial
di: Yan Zhao, et al.
Pubblicazione: (2025)

Efficacy and Safety of Oral Cyclosporine in Antihistamine Refractory Chronic Urticaria Among Children and Adolescents: A Retrospective Study
di: Davinder Parsad, et al.
Pubblicazione: (2025)

Global Burden of Elderly Atopic Dermatitis (1990–2021) and Projections to 2030: A Socio‐Demographic Index Analysis
di: Ruiqian Yao, et al.
Pubblicazione: (2025)

Real‐World Use of Topical Treatments for Atopic Eczema in Children and Young People: Systematic Review
di: Phuong Hua, et al.
Pubblicazione: (2026)

Variants at 8p21.3 Mediate BMP1 Expression, Contributing to Higher Atopic Dermatitis Risk
di: Jia Yi Karen Wong, et al.
Pubblicazione: (2026)

Unraveling the Natural History of Atopic Dermatitis: Prospective Disease Trajectories and Longitudinal IgE Sensitization from Birth to Adolescence
di: Kiwako Yamamoto‐Hanada, et al.
Pubblicazione: (2026)

Effects of Acupuncture as a Therapeutic Intervention Targeting Both Skin and Gastrointestinal Symptoms in Patients With Atopic Dermatitis: A Randomised Controlled Trial
di: Jundong Kim, et al.
Pubblicazione: (2026)

Featured Cover
di: Lichen Li, et al.
Pubblicazione: (2024)

Pathomechanism of Adverse Reactions to Biological Treatment of Inflammatory Skin Conditions
di: Lichen Li, et al.
Pubblicazione: (2024)

Phase Ib/ II Study of Preliminary Efficacy, Safety and Pharmacodynamics of MG ‐ K10 , a Humanised Monoclonal Antibody Targeting IL ‐ 4Rα , in Adult Chinese Patients With Asthma
di: Mo Xian, et al.
Pubblicazione: (2026)

Eosinophilic Oesophagitis in Adults: National Centre Retrospective Study in an Irish Cohort
di: Olga Fagan, et al.
Pubblicazione: (2025)

Correction to “Higher Prevalence of Dupilumab‐Induced Ocular Adverse Events in Atopic Dermatitis Compared to Asthma: A Daily Practice Analysis”
Pubblicazione: (2026)

Common Causative Drugs of Paediatric Drug‐Induced Dermatitis: A Population‐Based Study
di: Hyeyone Hwang, et al.
Pubblicazione: (2026)

Are Phenotypic Baseline Characteristics Related to Abolition of AHR After Benralizumab and Dupilumab?
di: Philipp Suter, et al.
Pubblicazione: (2026)